解放军医学杂志2025，Vol.50Issue(10)：1250-1255,6.DOI:10.11855/j.issn.0577-7402.0476.2024.1213
基于PSMA PET的人工智能在前列腺癌诊治中的应用进展
Artificial intelligence in the diagnosis and treatment of prostate cancer based on PSMA PET
摘要
Abstract
Prostate-specific membrane antigen(PSMA)positron emission tomography(PET)is currently a precise diagnostic imaging technology for prostate cancer(PCa).Artificial intelligence(AI)technologies,particularly machine learning and deep learning algorithms,when combined with PSMA PET,showed extensive potential applications in various aspects of PCa management.These include the diagnosis and differential diagnosis of primary tumors,staging,recurrence detection,and treatment planning for PCa.At present,a few AI models have received clinical approval.This paper reviews the application progress of AI combined with PSMA PET in the diagnosis and treatment of PCa,explores the current limitations of AI technologies in clinical practice,and aim to provide references to future diagnosis and treatment studies for PCa.关键词
前列腺癌/人工智能/前列腺特异性膜抗原/正电子发射体层成像Key words
prostate cancer/artificial intelligence/prostate-specific membrane antigen/positron emission tomography分类
临床医学引用本文复制引用
彭岱云,付静瑜,杨帆,柳江燕..基于PSMA PET的人工智能在前列腺癌诊治中的应用进展[J].解放军医学杂志,2025,50(10):1250-1255,6.基金项目
This work was supported by the Second Hospital of Lanzhou University"Cuiying Graduate Advisor"Training Program(CYDSPY202001)兰州大学第二医院"萃英研究生指导教师"培育计划(CYDSPY202001) （CYDSPY202001）
